Climb Bio (CLYM) Non-Current Assets (2020 - 2026)

Climb Bio has reported Non-Current Assets for 7 years, with the latest figure at $39.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 61.21% year-over-year to $39.0 million; the trailing twelve-month figure through Mar 2026 stood at $297.2 million (up 58.61% YoY), and the FY2025 full-year result was $61.9 million, down 0.67% from the prior year.
• Non-Current Assets for Q1 2026 stood at $39.0 million, down from $61.9 million in the prior quarter.
• The five-year high for Non-Current Assets was $105.0 million in Q2 2025, with the low at $21000.0 in Q2 2024.
• Historically, Non-Current Assets has averaged $32.0 million across 5 years, with a median of $17.0 million in 2022.
• Annual changes were most pronounced in 2024 — Non-Current Assets slumped 98.97% — and 2025, when it surged 499909.52%.
• Climb Bio's Non-Current Assets stood at $599000.0 in 2022, then plunged by 64.27% to $214000.0 in 2023, then surged by 29019.16% to $62.3 million in 2024, then dropped by 0.67% to $61.9 million in 2025, then slumped by 37.04% to $39.0 million in 2026.
• The last three Non-Current Assets figures came in at $39.0 million (Q1 2026), $61.9 million (Q4 2025), and $91.3 million (Q3 2025), per Business Quant data.